Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCNT1P5 is a predicted pseudogene in humans and is not known to encode an active protein product. Functional genes in this family, such as GCNT1, encode glycosyltransferases that catalyze the branching of O-glycans, but GCNT1P5 itself lacks evidence for protein expression and is not considered a functional enzyme or therapeutic target in drug discovery or clinical medicine. Pseudogenes like GCNT1P5 may arise through gene duplication or retrotransposition events; they typically do not produce functional protein products and consequently have no known biological or disease role. It is not recognized as a drug target, receptor, enzyme, transporter, or any canonical molecular target. There are no aliases, drugs, or disease associations for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosaminyl transferase 1 pseudogene 5 (GCNT1P5).